FibroBiologics Releases Third CYWC628 Batch for DFU Trial
Houston, Texas, United States, Aug 27, 2026 FibroBiologics, Inc. has released the third batch of CYWC628 drug product and...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Houston, Texas, United States, Aug 27, 2026 FibroBiologics, Inc. has released the third batch of CYWC628 drug product and...
Geneva, Switzerland , Aug 26, 2026 Spineart and eCential Robotics have announced that the U.S. Food and Drug Administration...
Durham, N.C., September 25, 2025 – HemoSonics LLC, a medical device innovator in acute bleeding management, has received 510(k)...
